1,3-di(4-imidazolinophenoxyl)propane has been researched along with ruthenium in 1 studies
| Studies (1,3-di(4-imidazolinophenoxyl)propane) | Trials (1,3-di(4-imidazolinophenoxyl)propane) | Recent Studies (post-2010) (1,3-di(4-imidazolinophenoxyl)propane) | Studies (ruthenium) | Trials (ruthenium) | Recent Studies (post-2010) (ruthenium) |
|---|---|---|---|---|---|
| 12 | 0 | 8 | 6,854 | 7 | 3,883 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blevins, ER; Boudreaux, CM; Brown, SR; Das, S; Gregory, SA; Kim, Y; Papish, ET; Qu, F; Sun, Y; Ward, NA | 1 |
1 other study(ies) available for 1,3-di(4-imidazolinophenoxyl)propane and ruthenium
| Article | Year |
|---|---|
Ruthenium pincer complexes for light activated toxicity: Lipophilic groups enhance toxicity.
Topics: Humans; Ligands; Magnetic Resonance Spectroscopy; Ruthenium | 2023 |